| Literature DB >> 24313765 |
Abstract
Our understanding of the clinical implications of eosinophilic airway inflammation has increased significantly over the last 20 years, aided by the development of noninvasive means to assess it. This pattern of airway inflammation can occur in a diverse range of airway diseases. It is associated with a positive response to corticosteroids and a high risk of preventable exacerbations. Our new understanding of the role of eosinophilic airway inflammation has paved the way for the clinical development of a number of more specific inhibitors that may become new treatment options. Different definitions, ideas of disease, and adoption of biomarkers that are not well known are necessary to fully realize the potential of these treatments.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24313765 DOI: 10.1513/AnnalsATS.201306-168AW
Source DB: PubMed Journal: Ann Am Thorac Soc ISSN: 2325-6621